MILANO 9 MAGGIO 2024
UNIVERSITA’ DI MILANO – VIA MANGIAGALLI 25 – 20133 MILANO
ORARIO: 8.30 – 17.15
Aim of the congress
The event will focus on the evolution of vaccines and advanced therapies production. New technologies and dedicated solutions are available today for the most suitable contamination control strategies and continuous improvement.
The callenge aspects of such different therapies will be considered as well as the criticality of products and productions that characterize the different manufacturings design.
Congress Venue
Milan University – Via Luigi Mangiagalli 25 – 20133 Milano
Meeting room: C03 (Floor -1)
Metro Station M2 – Piola
Partecipation
The partecipation is free of charge upon registration by 3rd May. Registration on-line
Seats are limited. Official language: Italian, with course material in English.
AGENDA
8.30 Registration
9.00 Welcome and introduction: AFI, ASCCA, ISPE, PDA Italy Chapter, UNIMI
9.30 The mosts challenges aspetc for ATMPs production: from autologous to the the future allogenic therapies
M.L. Nolli (AFI)
10.00 Development and improvement in the GMP production of ATMPs: what challenges for an academic hospital pharmaceutical workshop
M. Gunetti (Ospedale Pedriatrico Bambino Gesù – AFI)
10.30 Coffee Break and welcome from the sponsors
11.00 Evolution within the vaccine production
C. Campa (GSK Vaccines Siena – PDA Italy Chapter)
11.30 How to reach the CCS: a case study
A. Raso (GSK Vaccines Siena – PDA Italy Chapter)
12.00 Round table 1: meeting with the experts
12.30 Lunch break with the sponsors
13.15 Design overview & technical solutions for modern Biotech and ATMPs manufacturing facilities
M. Alberio (PharmaProcess – ISPE)
13.45 Risk-based and process-driven design of ATMP laboratories in hospital environment
F. Contegno (Aware Lab – ASCCA)
T. Dallavalle (Rise Italia – ASCCA)
14.15 Novel concept for isolators to manufacture advanced therapy medicinal products
K. Ushioda (Skan – ASCCA)
15.15 Coffee break with the sponsors
15.45 Robotics: Pharmaceutical manufacturing best practices and compliance
A. Tanzini (Staubli – ISPE)
16.15 Biotech product filling: improve contamination control using robotics and human-less approach
C. Bechini (Pharma-integration – ISPE)
16.45 Round table 2: meeting with the experts and end of the congress
